Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Clinical trial NCT02074839 · RECRUITING

Trial details

NCT number: NCT02074839
Sponsor: Institut de Recherches Internationales Servier
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Acute Myeloid Leukemia (AML)Untreated AML Other IDH1-mutated Positive Hematologic Malignancies Myelodysplastic Syndromes

Start date: 2014-03-01
Primary completion: 2026-12-31
Enrollment: 291

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.